AllianceBernstein
NAUT icon

AllianceBernstein’s Nautilus Biotechnolgy NAUT Stock Holding History

AllianceBernstein’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-22,760
Closed -$19.6K – 3293
2025
Q1 		$19.6K Buy
22,760
+1,300
+6% +$1.93K ﹤0.01% 3182
2024
Q4 		$36.1K Hold
21,460
– – ﹤0.01% 3199
2024
Q3 		$61.2K Buy
21,460
+700
+3% +$1.81K ﹤0.01% 3178
2024
Q2 		$48.6K Buy
20,760
+4,290
+26% +$11.2K ﹤0.01% 3192
2024
Q1 		$48.4K Hold
16,470
– – ﹤0.01% 3092
2023
Q4 		$49.2K Sell
16,470
-110
-0.7% -$315 ﹤0.01% 3130
2023
Q3 		$52.4K Buy
16,580
+740
+5% +$2.41K ﹤0.01% 3134
2023
Q2 		$61.3K Buy
+15,840
New +$45.6K ﹤0.01% 3120

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $750M AUM 25.77% 1-Year Est. Return
MVG
Madrona Venture Group Seattle, Washington $22.1M AUM 86.9% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.05B AUM 1.77% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $4.42B AUM 22.6% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
TM
Tikvah Management Charlotte, North Carolina $329M AUM 64.12% 1-Year Est. Return

AllianceBernstein's NAUT Position: Q2 2025 in Review

AllianceBernstein sold out of Nautilus Biotechnolgy (NAUT) in Q2 2025, closing a stake of 22,760 shares — an estimated $19.6K sold.

AllianceBernstein first reported a position in NAUT in Q2 2023 and held it in 8 quarters. The position peaked at $61.3K in Q2 2023. 71 funds tracked by Wall St. Rank hold NAUT as of Q2 2025.

  • AllianceBernstein reported no remaining Nautilus Biotechnolgy position as of Q2 2025 after selling out during the quarter.
  • AllianceBernstein sold 22,760 Nautilus Biotechnolgy shares in Q2 2025, an estimated $19.6K.
  • AllianceBernstein first reported a position in Nautilus Biotechnolgy in Q2 2023 and held it in 8 quarters.
  • AllianceBernstein's Nautilus Biotechnolgy position peaked at $61.3K in Q2 2023.
  • 71 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q2 2025.

Based on AllianceBernstein's 13F filing for Q2 2025, filed 14 Aug 2025.